21 December 2022
21 December 2022
AllPressGrowth
InfraVia Growth invests in Orakl Oncology to make cancer drug response predictable before clinical trials
LifeAllVideos
Supporting finance teams through transformation and growth
AllVideosGrowth
InfraVia Growth Equity AGM 2026
© 2026 InfraVia. We connect. We power. We grow.